The Food and Drug Administration has approved updated COVID-19 vaccines to protect against currently circulating variants, and the shots have shown to be more effective than the now-available ...

Doctors detail what we learned after the first season following the approval of RSV vaccines. The vaccine effectively prevented severe illness in older, but only 24 percent of eligible US adults ...

Additional data from the phase 3 trial showed the vaccine came with a 94.1% effectiveness in preventing severe RSV when people got it during the first season and 64.2% a year later, the company ...

New research shows that flu vaccines provide strong protection for children but underscores the need for improved efficacy against specific subtypes like H3N2. Rapid communication: Effectiveness ...

Studies have shown these vaccines to be effective, with the Pfizer, GSK, and Moderna vaccines preventing RSV pneumonia and bronchitis in more than 80% of participants. A recent study published in ...